CVE-2022-30277
CWE-613Published: June 2, 2022· Updated: Jun 17, 2026
Official Description
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
Technical Analysis
CVE-2022-30277 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires low privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), with a CVSS base score of 5.7.
CVSS v3.1 Vector Breakdown
Affected Vendors & Products
Exploit & PoC Resources
Official Patches & Advisories
All References (2)
Quick Facts
Related CVEs (CWE-613)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2022-30277 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts